US Surgical extends supply deal and offer for Circon:
This article was originally published in Clinica
US Surgical has extended its agreements with University HealthSystem Consortium for sutures, disposable staplers and laparoscopic instruments until June 2000. The extended contracts are expected to result in an additional $68 million for the US company. In a separate development, US Surgical has extended its hostile takeover offer for Circon until July 16. The price remains the same at $16.50 per share. US Surgical made its initial offer for Circon in August 1996 (see Clinica No 718, p 9).
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.